About Scopio Labs
Scopio Labs is a company based in Tel Aviv (Israel) founded in 2014.. Scopio Labs has raised $125 million across 7 funding rounds from investors including OurCrowd, Mizrahi-Tefahot Bank and Kreos Capital. Scopio Labs offers products and services including Scopio X100, Scopio X100HT, and Peripheral Blood Smear Application. Scopio Labs operates in a competitive market with competitors including PathAI, Deepcell, Aignostics, Definiens and Akoya Biosciences, among others.
- Headquarter Tel Aviv, Israel
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$125 M (USD)
in 7 rounds
-
Latest Funding Round
$10 M (USD), Series D
Jul 25, 2025
-
Investors
OurCrowd
& 12 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Scopio Labs
Scopio Labs offers a comprehensive portfolio of products and services, including Scopio X100, Scopio X100HT, and Peripheral Blood Smear Application. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Digital system for small labs to analyze blood smears at high resolution.
High-throughput platform for advanced bone marrow and blood diagnostics.
AI tool for evaluating blood cell morphology and differentials.
Unlock access to complete
Funding Insights of Scopio Labs
Scopio Labs has successfully raised a total of $125M across 7 strategic funding rounds. The most recent funding activity was a Series D round of $10 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series D — $10.0M
-
First Round
First Round
(24 May 2017)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Series D - Scopio Labs | Valuation |
investors |
|
| Jul, 2024 | Amount | Series D - Scopio Labs | Valuation | Fortissimo Capital |
|
| Sep, 2022 | Amount | Debt – Conventional - Scopio Labs | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Scopio Labs
Scopio Labs has secured backing from 13 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include OurCrowd, Mizrahi-Tefahot Bank and Kreos Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture debt is provided to growth-stage companies across multiple sectors.
|
Founded Year | Domain | Location | |
|
Private equity firm focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Scopio Labs
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Scopio Labs
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Scopio Labs Comparisons
Competitors of Scopio Labs
Scopio Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Deepcell, Aignostics, Definiens and Akoya Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| domain | founded_year | HQ Location |
AI-powered single cell classification and isolation technology for clinical research
|
|
| domain | founded_year | HQ Location |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| domain | founded_year | HQ Location |
Provides image analysis and data mining solutions for quantitative digital pathology in the healthcare industry
|
|
| domain | founded_year | HQ Location |
Provider of solutions for rapid proteomic profiling
|
|
| domain | founded_year | HQ Location |
AI-based tools for pathological image analysis are provided to labs.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Scopio Labs
Frequently Asked Questions about Scopio Labs
When was Scopio Labs founded?
Scopio Labs was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Where is Scopio Labs located?
Scopio Labs is headquartered in Tel Aviv, Israel.
Is Scopio Labs a funded company?
Scopio Labs is a funded company, having raised a total of $125M across 7 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $15M, raised on May 24, 2017.
What does Scopio Labs do?
Provider of computational imaging-based digital microscopes image analysis tools. The products of the company include Scopio X100 and Scopio X100HT for Peripheral Blood Smear and veterinary applications. Claims that its products enable clinical and research improvements in the areas such as cancer, hematology, and cytology as well as help in academic research and drug discovery.
Who are the top competitors of Scopio Labs?
Scopio Labs's top competitors include Aignostics, Pictor Labs and PathAI.
What products or services does Scopio Labs offer?
Scopio Labs offers Scopio X100, Scopio X100HT, and Peripheral Blood Smear Application.
Who are Scopio Labs's investors?
Scopio Labs has 13 investors. Key investors include OurCrowd, Mizrahi-Tefahot Bank, Kreos Capital, European Union, and Ilex Medical.